Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1999
11/04/1999WO1999048894B1 Novel cephalotaxane derivatives and process for their preparation
11/04/1999WO1999045909A3 Use of nitrone compounds for the inhibition of angiogenesis
11/04/1999WO1999043355A3 Formulations containing oxaliplatin
11/04/1999WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999042090A3 Treating cancer
11/04/1999WO1999040837A3 Compositions for detecting and surgically removing lymphoid tissue involved in tumor progression
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999034004A3 Metastatic breast and colon cancer regulated genes
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999019481A3 Mammalian genes involved in viral infection and tumor suppression
11/04/1999DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999CA2565375A1 Polyol-ifn-beta conjugates
11/04/1999CA2330451A1 Polyol-ifn-beta conjugates
11/04/1999CA2329897A1 Polysaccharide-antigen conjugates
11/04/1999CA2328992A1 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
11/04/1999CA2328165A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999CA2326825A1 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326824A1 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2323235A1 Adenoviral vectors for treating disease
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999EP0953351A2 Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
11/03/1999EP0953049A2 Novel human metallothionein
11/03/1999EP0952975A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
11/03/1999EP0952974A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/03/1999EP0952853A2 Conjugate comprising an active agent, a polypeptide and a polyether
11/03/1999EP0952843A2 Pharmaceutical formulations for sustained drug delivery
11/03/1999EP0952842A2 A method of treating cancer
11/03/1999EP0754033B1 Heterofunctional, mucoadhesive dosage form
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1233961A Apoptosis inducers
11/03/1999CN1233957A Pharmaceutical compositions
11/03/1999CN1233498A Ingredients for food beneficial for coronary heart disease patient and tumor patient
11/03/1999CN1233493A Oral liquor having functions of inhibiting tumor and regulating immunization
11/03/1999CN1233483A Traditional Chinese medicine for treating cirrhosis and liver cancer
11/03/1999CN1233476A Medicine for treating acute leukemia, and method for preparing same
11/02/1999US5977386 Antitumor
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999US5977332 Oligonucleotides having 2'-ether groups
11/02/1999US5977329 Methods of synthesizing GM3
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977187 4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growth
11/02/1999US5977163 Water soluble paclitaxel prodrugs
11/02/1999US5977151 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
11/02/1999US5977128 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
11/02/1999US5977109 Sacchrides, storage stability, antitumor
11/02/1999US5977108 Leukemia
11/02/1999US5977102 Inhibitory effect on signal transduction mediated by tyrosine kinases or epidermal growth factor; antitumor,-carcinogenic, -metastasis,-proliferation agents and -inflammatory agents; psoriasis; angiogenesis inhibitors; immunology;
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976845 Composite antibodies of human subgroup IV light chain capable of binding to TAG-72
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976531 Composite antibodies of human subgroup IV light chain capable of binding to tag-72
11/02/1999US5976528 Used to decrease the risk of chemical carcinogenesis comprising administering to a subject in need of such treatment an effective amount.
11/02/1999US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
11/02/1999CA2077621C Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
10/1999
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054459A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054444A2 Combination therapy using nucleic acids and radio therapy
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054330A1 2,3-olefinic epothilone derivatives
10/28/1999WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999WO1999054319A1 12,13-modified epothilone derivatives
10/28/1999WO1999054318A1 12,13-cyclopropane epothilone derivatives
10/28/1999WO1999054310A2 New substituted amides, their production and their use
10/28/1999WO1999054308A1 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
10/28/1999WO1999054293A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999WO1999054286A2 Btk inhibitors and methods for their identification and use
10/28/1999WO1999053960A2 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999WO1999053952A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum
10/28/1999WO1999053949A2 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999053937A1 Immunopotentiators and antitumor agents
10/28/1999WO1999053920A1 Use of vitamin pp compounds
10/28/1999WO1999053912A1 Topical immunostimulation to induce langerhans cell migration
1 ... 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 ... 2211